Funding
Turn ideas into impact
Show Me
Due: November 16, 2027
Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-331
Due: November 16, 2027
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-244
Due: November 18, 2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
US $300,000
Type
Grant
Source
Federal
Opp Number
RFA-DA-26-034
Due: November 20, 2027
DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
Type
Cooperative Agreement
Source
Federal
Opp Number
W911NF-23-S-0001
Due: December 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-DA-26-056
Due: December 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-DA-26-055
Due: December 3, 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
US $275,000
Type
Grant
Source
Federal
Due: December 23, 2027
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 – Clinical Trials Not Allowed)
US $350,000
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-016
Due: December 23, 2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products – Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 – Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-HL-26-018
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?